Search results
Results from the WOW.Com Content Network
Lokivetmab, trade name Cytopoint, is a monoclonal antibody used to treat atopic dermatitis in dogs. [1] It acts against interleukin 31 (IL-31), [2] which is a cytokine involved in causing itchiness (pruritus). [2] Lokivetmab is administered by subcutaneous injection; each dose is effective for four to eight weeks. [3]
Description - includes the proprietary name (if any), nonproprietary name, dosage form(s), qualitative and/or quantitative ingredient information, the pharmacologic or therapeutic class of the drug, chemical name and structural formula of the drug, and if appropriate, other important chemical or physical information, such as physical constants ...
take (often effectively a noun meaning "prescription"—medical prescription or prescription drug) rep. repetatur: let it be repeated s. signa: write (write on the label) s.a. secundum artem: according to the art (accepted practice or best practice) SC subcutaneous "SC" can be mistaken for "SL," meaning sublingual. See also SQ: sem. semen seed
Tesla CEO Elon Musk has become the first person to top a net worth of $400 billion, according to Bloomberg News. Musk's wealth, which was last counted at $384 billion by the Bloomberg Billionaires ...
The former star athlete who stabbed his ex-girlfriend and her mother in a frenzied parking lot attack in Florida last summer — before slashing his own throat — still had the scars of his ...
When used as drugs, the International Nonproprietary Names (INNs) end in -mab. The remaining syllables of the INNs, as well as the column Source, are explained in Nomenclature of monoclonal antibodies. Types of monoclonal antibodies with other structures than naturally occurring antibodies.
It’s been three weeks since the general election polls closed on Nov. 5, and there are still three races for the U.S. House of Representatives that remain too close to call: two in California ...
The experimental protocol was explained to a group of twelve nurses and twenty-one nursing students, who were asked to predict how many nurses would give the drug to the patient; ten nurses and all the nursing students said they would not do it. Hofling then selected 22 nurses at a hospital in the United States for the actual experiment.